EUCTR2013-003795-13-BE进行中（未招募）1 期
ong-term follow-up study to monitor the growth and development of pediatric patients previously treated with everolimus in study CRAD001M2301 - EXIST-LT
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Pediatric female patients who were on study treatment in study CRAD001M2301 within the past 3 months and have not reached Tanner Stage V or age 17 at the time of completion of study CRAD001M2301
- •2. Pediatric male patients who were on study treatment in study CRAD001M2301 within the past 3 months and have not reached Tanner Stage V or age 17 at the time of completion of study CRAD001M2301.
- •3. Written informed consent according to local guidelines.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 48
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Pediatric female patients who were on study treatment in study CRAD001M2301 and have not reached Tanner Stage V but are within 3 month of turning age 16
- •2. Pediatric male patients who were on study treatment in study CRAD001M2301 and have not reached Tanner Stage V but are within 3 months of turning age 17
- •3. Any patient who was pregnant prior to start of study CRAD001M2305
研究者
相似试验
进行中（未招募）
1 期
ong-term monitoring of growth and development of pediatric patients previously treated with everolimusSubependymal Giant Cell Astrocytoma (SEGA) associated with Tuberous Sclerosis Complex (TSC)MedDRA version: 17.1Level: PTClassification code 10045138Term: Tuberous sclerosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2013-003795-13-PLovartis Pharma Services AG48
招募中
不适用
ong-term observational study to assess the development of Endocrine late effects and Osteopathologies in juvenile survivors of Paediatric MalignanciesC00-D48E00-E90NeoplasmsEndocrine, nutritional and metabolic diseasesDRKS00009841niversitätsklinikum Essen1,500
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for X-linked Retinitis PigmentosaEUCTR2018-000425-31-Outside-EU/EEAJanssen-Cilag International NV
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for X-linked Retinitis PigmentosaX-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0 Level: PT Classification code 10038914 Term: Retinitis pigmentosa System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-000425-31-GBMeiraGTx UK II Ltd36
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for LCA2 OPTIRPE65eber Congenital Amaurosis (LCA) caused by mutations in RPE65MedDRA version: 20.0Level: PTClassification code 10070667Term: Leber's congenital amaurosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-000898-20-GBMeiraGTx UK Ltd27